Paul Aisen M.D.

Paul Aisen, NIA-appointed Director of the Alzheimer’s Disease Cooperative Study and Professor of Neurosciences at the University of California, San Diego, has been conducting therapeutic research on Alzheimer’s disease for the past two decades. Dr. Aisen’s research focuses on inflammatory mechanisms in the brain and the development of new treatment strategies for Alzheimer’s disease and other neurodegenerative diseases. As Director of the ADCS, he collaborates with pharmaceutical companies on drug development and designing and directing multicenter randomized controlled trials to evaluate the safety and efficacy of new treatments. Therapeutic approaches under investigation include secretase modulators, amyloid-binding compounds, cholinesterase inhibitors, nicotine, antioxidants and anti-inflammatory drugs.

Apr 192010
 

Readers, As promised, I want to share some findings presented at the Annual American Academy of Neurology meeting held last week in Toronto, Canada. The is the major meeting for clinical neurologists in this country; it is huge and hectic. And while in recent years there has been a tendency for new data related to Alzheimer’s disease to be presented at conferences devoted entirely to AD (eg, the International Confernece on Alzheimer’s Disease, ICAD), there […]

Apr 062010
 

Readers, Still in an introductory mode, I would like to point you to some of the most valuable and reliable web sites for information related to Alzheimer’s disease (in addition, of course, to our own: www.adcs.org). First is ADEAR, the Alzheimer’s Disease Education and Referral site managed by the National Institute on Aging, a branch of NIH and our primary source of funds. The ADEAR web address is www.nia.nih.gov/alzheimers. ADEAR is an authoritative source of […]

Alz.org main site  |  Research  |  Advocacy  |  Care and support  |  Message boards  |  Disclaimer  |  Donate  |  Contact us  |  Sign up for e-news
© 2011 Alzheimer's Association | Blog Suffusion theme by Sayontan Sinha